Abstract
This chapter presents a general overview of pharmaceutically used polymers with respect to their physicochemical characteristics and factors affecting drug delivery abilities. Pharmaceutical polymers, chemical structure, and properties are discussed for their applications in controlled drug release systems. An additional focus is on new polymers (dendrimers, hyperbranched polymers), considering their chemical versatility, uniqueness, and future implications. Problems associated with controlled drug release systems are also highlighted. Finally, applications of FDA-approved polymers used for oral drug delivery systems are outlined.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- Ab:
-
Antibody
- API:
-
Active pharmaceutical ingredient
- C max :
-
Concentration maximum
- CRS:
-
Controlled released system
- DDS:
-
Drug delivery system
- EPR:
-
Enhanced permeability and retention
- FDA:
-
Food and Drug Administration (USA)
- G2 (PAMAM):
-
Generation 2 polyamidoamine dendrimers
- GR:
-
Gastro-retentive delivery systems
- HPMA:
-
N-(2-Hydroxypropyl)methacrylamide
- HPMC:
-
Hydroxypropylmethylcellulose
- IgG:
-
Human immunoglobulinG
- M w :
-
Molecular weight
- mPEG-OH:
-
Polyethylene glycol monomethyl ether
- PAA:
-
Poly(acrylic acid)
- PAMAM:
-
Polyamidoamine
- PDDS:
-
Pulsatile drug delivery system
- PDI:
-
Polydispersity index
- PEG:
-
Poly(ethylene glycol)
- PEO:
-
Poly(ethylene oxide)
- PGA:
-
Poly(glutamic acid)
- pk a :
-
Acid dissociation constant
- PLA:
-
Polylactic acid
- PLGA:
-
poly(lactic-co-glycolic acid) copolymer
- PMMA:
-
Polymethylmethacrylate
- PVA:
-
Poly vinyl alcohol
- RES:
-
Reticular endothelium system
References
Abuchowski A, Van Es T, Palczuk NS, Davis FF (1997) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252:3578–3581
Alakhov V, Pietrzynski G, Patel K, Kabanov A, Bromberg L, Hatton TA (2004) Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. J Pharm Pharmacol 56:1233–1241
Arora S, Ali A, Ahuja A, Baboota S, Qureshi J (2006) Pulsatile drug delivery systems: An approach for controlled drug delivery. Ind J Pharm Sci 68:295–300
Bergsma EJ, Rozema FR, Bos RR, de Bruijn WC (1993) Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for the fixation of unstable zygomatic fractures. J Oral Maxillofac Surg 51:666–670
Betancourt T, Brown B, Brannon-Peppas L (2007) Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine 2:219–232
Boldhane S (2008) Development and evaluation of oral platform drug delivery technology. In: Shivaji University, vol Ph.D. Thesis pp 12–13
Brazel CS, Peppas NA (2000) Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 49:47–58
Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group. Lancet 345:1008–1012
Bromberg L (2008) Polymeric micelles in oral chemotherapy. J Control Release 128:99–112
Chasin M, Domb A, Ron E, Mathiowitz E, Langer R, Leong K, Laurencin C, Brem H, Grossman S (1990) Polyanhydrides as drug delivery systems. In: Chasin M, Langer R (eds) Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, pp 43–70
Choi BY, Park HJ, Hwang SJ, Park JB (2002) Preparation of alginate beads for floating drug delivery system: effects of CO2 gas-forming agents. Int J Pharm 239:81–91
Chourasia MK, Jain SK (2003) Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Sci 6:33–66
Colombo P, Santi P, Bettini R, Prazel CS, Peppas NA (2000) Mechanism-based classification of controlled release devices. In: Wise DL (ed) Handbook of pharmaceutical controlled release technology. CRC Press, New York, p 493
David A, Kopeckova P, Kopecek J, Rubinstein A (2002) The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells. Pharm Res 19:1114–1122
de Leeuw BJ, Lueben HL, Pérard D, Verhoef AC, de Boer AG, Junginger HE (1995) The effect of mucoadhesive poly(acrylates) polycarbophil and carbomer on zinc and calcium dependent proteases. Proc Int Symp Control Rel Bioact Mater 22:528–529
Degussa (2001) http://www.degussa-history.com/geschichte/en/inventions/eudragit/in:
Dittigen M, Fricke S, Timpe C, Gercke H, Eichardt A (2000) Method of making a perorally administered solid drug with controlled effective ingredient delivery. US Patent No 6117450, USA
Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347–360
Duncan R, Seymour L (2007) Hiroshi Maeda–defining the pathway to targeted cancer therapy. J Drug Target 15:456
FDA (2004) http://www.fda.gov/medwatch/SAFETY/2004/jul_PI/CiproXR_PI.pdf
FDA (2006a) http://www.fda.gov/cder/foi/label/2006/018936s076lbl.pdf
FDA (2006b) http://www.fda.gov/medwatch/safety/2006/Paxil%20CR_PI.pdf
FDA (2008a) http://www.fda.gov/cder/dmpq
Field JR, Stanley RM (2004) Suture characteristics following incubation in synovial fluid or phosphate buffered saline. Injury 35:243–248
Ford JE (1994) Fundamental aspects of drug release form hydrophilic matrix tablets. In: Proc Colorcon Controlled Release Symposium, pp 1–26
Gazzaniga A, Palugan L, Foppoli A, Sangalli ME (2008) Oral pulsatile delivery systems based on swellable hydrophilic polymers. Eur J Pharm Biopharm 68:11–18
Guyot M, Fawaz F (2000) Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int J Pharm 204:171–182
Haag R, Kratz F (2006) Polymer therapeutics: concepts and applications. Angew Chem Int Ed 45:1170–1179
Haag R, Sunder A, Stumbé JF (2000) An approach to glycerol dendrimers and pseudo-dendritic polyglycerols. J Am Chem Soc 122:2954–2955
Hamdan AM, Moseke C, Blanco L, Barralet JE, Lopez-Carbacos E, Gbureck U (2008) Strontium modified biocements with zero order release kinetics. Biomaterials 29:4691–4697
Haus E (2007) Chronobiology in the endocrine system. Adv Drug Deliv Rev 59:985–1014
Hebden JM, Wilson CG, Spiller RC, Gilchrist PJ, Blackshaw E, Frier ME, Perkins AC (1999) Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm Res 16:1087–1092
Jian-Hwa G (2003) Carbopol®® polymers for pharmaceutical drug delivery applications. Drug Del Tech 3:6
Khandare JJ, Minko T (2006) Polymer-drug conjugates: progress in polymeric prodrugs. Progress Polymer Sci 31:359–397
Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T (2006) Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug Chem 17:1464–1472
Kopecek J, Bazilova H (1973) Poly(N-(hydroxypropyl)-methacrylamide) radical polymerization and copolymerization. Eur Polym J 9:7–14
Langer R, Chasin M (1990) Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, p 47
Laurencin C, Domb A, Morris C, Brown V, Chasin M, McConnell R, Lange N, Langer R (1990) Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. J Biomed Mater Res 24:1463–1481
Lee WC, Chu IM (2008) Preparation and degradation behavior of polyanhydrides nanoparticles. J Biomed Mater Res B Appl Biomater 84:138–146
Lee CC, MacKay JA, Frechet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23:1517–1526
Lee H, Lee K, Park TG (2008) Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem 19:1319–1325
Lehr CM, Bouwstra JA, Tukker JJ, Junginger HE (1990) Intestinal transit of bioadhesive microspheres in an in situ loop in the rat: a comparative study with copolymers and blends based on poly(acrylic acid). J Control Release 13:51–62
Lehr CM, Bouwstra JA, Bodde HE, Junginger HE (1992) A surface energy analysis of mucoadhesion: contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharm Res 9:70–75
Lieberman HA, Lachman L, Schwartz JB (1990) Pharmaceutical dosage forms: tablets. Marcel Dekker, New York, pp 118–233
Majoros IJ, Thomas TP, Mehta CB, Baker JR Jr (2005) Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem 48:5892–5899
Majoros IJ, Williams CR, Baker JR Jr (2008) Current dendrimer applications in cancer diagnosis and therapy. Curr Top Med Chem 8:1165–1179
McLeod AD, Friend DR, Tozer TN (1993) Synthesis and chemical stability of glucocorticoid–dextran esters: potential prodrugs for colon-specific delivery. Int J Pharm 92:105–114
Mehvar R, Dann RO, Hoganson DA (2000) Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes. J Control Release 68:53–61
Middleton JC, Tipton AJ (1998) Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21:2335–2346
Minko T, Khandare JJ, Jayant S (2007) Polymeric Drugs. In: Matyjaszewski K, Gnanou Y, Leibler L (eds) Macromolecular engineering: from precise macromolecular synthesis to macroscopic material properties and application. Wiley-VCH, Weinheim, pp 2541–2595
Mura P, Maestrelli F, Cirri M, Gonzalez Rodriguez ML, Rabasco Alvarez AM (2003) Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline. J Drug Target 11:365–371
Newcome GR, Moorefield CN, Keith JN, Baker GR, Escamilla GH (1994) Chemistry within a unimolecular micelle precursor: Boron superclusters by site- and depth-specific transformations of dendrimers. Angew Chem Int Ed 33:2413–2420
Papp I, Dernedde J, Enders S, Haag R (2008) Modular synthesis of multivalent glycoarchitectures and their unique selectin binding behavior. Chem Commun 44:5851–5853
Park TG, Cohen S, Langer RS (1994) Controlled drug delivery using polymer/pluronic blends. US Patent No. 5330768 USA
Pendri A, Martinez A, Xia J, Shorr RG, Greenwald RB (1995) Poly(ethylene glycol) fluorescent linkers. Bioconjug Chem 6:596–598
Perez-Marcos B, Gutierrez C, Gomez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A (1991) Usefulness of certain varieties of Carbopol in the formulation of hydrophilic furosemide matrices. Int J Pharm 67:113–121
Quadir MA, Radowski MR, Kratz F, Licha K, Hauff P, Haag R (2008) Dendritic multishell architectures for drug and dye transport. J Control Release: 132:289–294
Rihova B, Bilej M, Vetvicka V, Ulbrich K, Strohalm J, Kopecek J, Duncan R (1989) Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. Biomaterials 10:335–342
Ross AC, MacRae RJ, Walther M, Stevens HN (2000) Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol 52:903–909
Roy P, Shahiwala A (2009) Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release 134:74–80
Santus C, Baker (1995) Osmotic drug delivery: a review of the patent literature. J Control Release 35:1–21
Shishu GN, Aggarwal N (2007) Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads. AAPS PharmSciTech 8:48
Shive MS, Anderson JM (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5–24
Smolensky MH, Peppas NA (2007) Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 59:828–851
Stiribara SE, Frey H, Haag R (2002) Dendritic polymers in biomedical applications: from potential to clinical use in diagnosis and therapy. Angew Chem Int Ed 41:1329–1334
Streubel A, Siepmann J, Bodmeier R (2002) Floating microparticles based on low density foam powder. Int J Pharm 241:279–292
Sunder A, Hanselmann R, Frey H, Mulhaupt R (1999) Controlled synthesis of hyperbranched polyglycerols by ring-opening multibranching polymerization. Macromolecules 32:4240–4246
Sunder A, Mülhaupt R, Haag R, Frey H (2000) Hyperbranched polyether polyols: a modular approach to complex polymer architectures. Adv Mater 12:235–239
Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H (2001) Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm 215:263–267
Takada K (1997) Controlled-release preparations. US Patent No 5,637,319, USA
Tiainen J, Veiranto M, Suokas E, Tormala P, Waris T, Ninkovic M, Ashammakhi N (2002) Bioabsorbable ciprofloxacin-containing and plain self-reinforced polylactide-polyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones. J Craniofac Surg 13:427–433
Tomalia DA, Fréchet JM (2005) Introduction to dendrimers and dendritic polymers. Prog Polym Sci 30:294–324
Türk H, Haag R, Alban S (2004) Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system. Bioconjug Chem 15:162–167
Türk H, Shukla A, Alves Rodrigues PC, Rehage H, Haag R (2007) Water-soluble dendritic core-shell-type architectures based on polyglycerol for solubilization of hydrophobic drugs. Chemistry 13:4187–4196
Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM (1999) Polymeric systems for controlled drug release. Chem Rev 99:3181–3198
Ulbrich K, Etrych T, Chytil P, Jelinkova M, Rihova B (2003) HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. J Control Release 87:33–47
Venuganti VV, Perumal OP (2008) Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int J Pharm 361:230–238
Wang L, Kristensen J, Ruffner DE (1998) Delivery of antisense oligonucleotides using HPMA polymer: synthesis of thiol polymer and its conjugation to water-soluble molecules. Bioconjug Chem 9:749–757
Wang D, Kopeckova JP, Minko T, Nanayakkara V, Kopecek J (2000) Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers. Biomacromolecules 1:313–319
Yang L, Eshraghi J, Fassihi R (1999) A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J Control Release 57:215–222
Zhou J, Wu J, Hafdi N, Behr J-P, Erbacher P, Peng L (2006) PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun 14:2362–2364
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Khandare, J., Haag, R. (2010). Pharmaceutically Used Polymers: Principles, Structures, and Applications of Pharmaceutical Delivery Systems. In: Schäfer-Korting, M. (eds) Drug Delivery. Handbook of Experimental Pharmacology, vol 197. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00477-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-00477-3_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00476-6
Online ISBN: 978-3-642-00477-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)